|
Table of Contents for this page
Report to the Nation - 2004
Prostate Cancer Treatment Can Be Risky
Drug Combo May Fight Prostate Cancer
Statins, NSAIDs vs. Prostate Cancer
Management of bone metastases in advanced prostate cancer
Understanding Peripheral Neuropathy
Report to the Nation - 2004
Prostate cancer is a high-profile disease due to its high incidence, the large number of men dying yearly from the disease, the considerable controversy surrounding the benefit and risks of early detection, and the fact that no consensus exists for the management of many stages of this disease. In this Report to the Nation on Prostate Cancer, we have coordinated the efforts of 22 leading experts in prostate cancer treatment and research from diverse backgrounds, subspecialties, and institutions to address the major therapeutic issues in the management of the disease. Within each chapter, the authors present not only a summary of what is currently known, but also a reminder of how much remains to be explored. You may download this PDF file and print by clicking "here"
Prostate Cancer Treatment Can Be Risky
Hormone Treatment May Have Adverse Effects for Some Patients
By Charlene Laino
WebMD Medical News
Reviewed by Brunilda Nazario, MD
Feb. 18, 2008 (San Francisco) -- For some men with prostate cancer, the risks of a common treatment may outweigh the benefits, new research suggests.
At issue is androgen deprivation therapy to lower levels of male hormones that can fuel prostate cancer growth. Alternately called hormone treatment or ADT, it's a well-accepted treatment for men with advanced cancer that has spread outside the prostate. ADT can be done by orchiectomy (removal of the testicles) or hormone therapy alone to reduce the production of male hormones; it also may be done in combination with anti-androgens, which block the effect of male hormones.
Click here for this excellent article on the damage that can be done by hormonal ablation therapy (HT). If you are considering HT or presently on HT - read this article.
Drug Combo May Fight Prostate Cancer
Thalidomide Plus Avastin Shows Promise for Treatment of Advanced Prostate Cancer
By Charlene Laino
WebMD Medical News
Reviewed by Brunilda Nazario, MD
Feb. 18, 2008 (San Francisco) -- A drug cocktail that starves tumors of their blood supply shows promise for the treatment of men with advanced prostate cancer.
A combination of Avastin and thalidomide -- both of which cut off the growth of new blood vessels that feed tumors, but in different ways -- appears to pack a more potent punch than Avastin alone, researchers report.
Click here to find out more information about this cocktail.
Statins, NSAIDs vs. Prostate Cancer
Cholesterol-Lowering Drugs and Anti-inflammatory Drugs May Extend Lives of Prostate
By Charlene Laino
WebMD Medical News
Reviewed by Louise Chang, MD
Feb. 18, 2008 (San Francisco) -- Men with prostate cancer who take cholesterol-lowering statin drugs or anti-inflammatory drugs live longer than those who don't take the drugs, a new study suggests.
"We found an association between both statin and NSAID use and the risk of dying of any cause," says researcher Matthew Katz, MD, of Saints Medical Center in Lowell, Mass.
For more information on the above click here.
Management of bone metastases in advanced prostate cancer
By Oliver Sartor MD and Steven J. diBiase MD
Perhaps as a result of increasing public awareness of prostate cancer and the widespread use of prostate specific antigen (PSA)-based screening, more cases of early stage disease are being diagnosed, while the incidence of metastatic disease at diagnosis is declining. Between 1984 and 1991, 30 to 40 percent of men with prostate cancer presented with advanced disease [1], while at present, only 5 percent of men have metastases at initial presentation
Click "here" to access the complete paper above.
Understanding Peripheral Neuropathy from Cancer Care
Because there are many causes of peripheral neuropathy, it’s important to get the right diagnosis.
People living with cancer may experience nerve symptoms, which they often describe as pain, tingling, burning, or numbness. Some people with cancer also have problems with coordination. All of these symptoms may be caused by peripheral neuropathy.
Click "here" to access the PDF booklet.
|